S
Segal Trials | Behavioral Clinical Research, Inc.
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
SEP-363856
Buprenorphine
MK-8189
KarXT
STS101
MK-8189-008
Psilocybin
AEF0117
JZP150
Parent organization
This site is a part of Segal Trials
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Active trials
2 of 10 total trials
An Extension study to a clinical study that will continue to evaluate the effectiveness and safety of SEP-363856 in people with schizophrenia that sw...
Invitation-only
Schizophrenia
Drug: SEP-363856
Locations recently updated
Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)
Enrolling
Treatment Resistant Depression
Drug: Psilocybin
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Trial sponsors
A
C
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems